AdaptHealth Corp. (AHCO) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AHCO SEC filings page.
AdaptHealth Corp. (AHCO) reported $3.4B in revenue over the twelve months to Jun 30, 2026, up 8.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is essentially flat, but earnings weakened while cash generation stayed positive and short-term liquidity tightened.
The 2025 gap between operating cash flow of$602M and a net loss of$71M indicates cash production is stronger than accounting profit, shaped more by non-cash items and working-capital timing than by bottom-line earnings. That conversion persisted after reinvestment: free cash flow was$219M , even as the current ratio reached only 1.0x, leaving less short-term cushion than the cash-flow figure alone suggests.
Revenue was nearly unchanged at
Debt-to-equity eased from 1.3x to 1.1x by FY2025, indicating leverage moderated. Yet the current ratio was only 1.0x, so improved leverage coexists with limited short-term balance-sheet flexibility.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of AdaptHealth Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
AdaptHealth Corp. has an operating margin of 2.8%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 25/100, suggesting thin profitability after operating expenses. This is down from 8.1% the prior year.
AdaptHealth Corp.'s revenue declined 0.5% year-over-year, from $3.3B to $3.2B. This contraction results in a growth score of 33/100.
AdaptHealth Corp. has elevated debt relative to equity (D/E of 1.13), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 18/100, reflecting increased financial risk.
AdaptHealth Corp.'s current ratio of 1.02 is below the typical benchmark, resulting in a score of 19/100. This tight liquidity could limit financial flexibility if cash inflows slow.
AdaptHealth Corp. has a free cash flow margin of 6.8%, earning a moderate score of 52/100. The company generates positive cash flow after capital investments, but with room for improvement.
AdaptHealth Corp. posts a -4.7% return on equity (ROE), meaning it loses $5 for every $100 of shareholders' equity. This results in a returns score of 25/100. This is down from 5.8% the prior year.
AdaptHealth Corp. scores 0.79, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
AdaptHealth Corp. passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
AdaptHealth Corp. reported a net loss of $70.8M while generating $601.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
AdaptHealth Corp. earns $0.88 in operating income for every $1 of interest expense ($90.9M vs $103.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
AdaptHealth Corp. generated $740.3M in revenue in Q2 2026. This represents an increase of 12.7% from the same quarter a year earlier. Against the prior quarter it is down 9.7%.
AdaptHealth Corp.'s EBITDA was -$18.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 111.5% from the same quarter a year earlier. Against the prior quarter it is down 116.0%.
AdaptHealth Corp. reported -$133.9M in net income in Q2 2026. This represents a decrease of 1012.7% from the same quarter a year earlier. Against the prior quarter it is down 735.0%.
AdaptHealth Corp. earned -$0.99 per diluted share (EPS) in Q2 2026. This represents a decrease of 1090.0% from the same quarter a year earlier. Against the prior quarter it is down 725.0%.
Cash & Balance Sheet
AdaptHealth Corp. recorded an outflow of $20.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 128.6% from the same quarter a year earlier. Against the prior quarter it is up 23.8%.
AdaptHealth Corp. carried $1.9B in long-term debt as of Q2 2026; cash and equivalents are not reported for that period.
Not reported for Q2 2026.
Margins & Returns
AdaptHealth Corp.'s gross margin was 14.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 6.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.
AdaptHealth Corp.'s operating margin was -18.6% in Q2 2026, reflecting core business profitability. This is down 28.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 19.3 percentage points.
AdaptHealth Corp.'s net profit margin was -18.1% in Q2 2026, showing the share of revenue converted to profit. This is down 20.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 16.1 percentage points.
AdaptHealth Corp.'s ROE was -9.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 10.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.7 percentage points.
Capital Allocation
AdaptHealth Corp. invested $166.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 87.5% from the same quarter a year earlier. Against the prior quarter it is up 37.2%.
Not reported for Q2 2026.
Not reported for Q2 2026.
AHCO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $740.3M+12.7% | $819.8M+5.4% | $989.6M+15.5% | $820.3M+1.8% | $657.1M-18.5% | $777.9M-1.8% | $856.6M-0.2% | $805.9M+0.2% |
| Cost of Revenue | $636.1M+22.0% | $708.3M+7.7% | $798.5M+20.2% | $658.4M+2.3% | $521.3M-18.1% | $657.4M+3.5% | $664.4M+20.0% | $643.8M-7.2% |
| Gross Profit | $104.2M-23.3% | $111.5M-7.4% | $191.0M-0.6% | $161.9M-0.1% | $135.8M-19.8% | $120.4M-23.5% | $192.2M-36.9% | $162.1M+46.6% |
| SG&A Expenses | $96.1M+0.9% | $95.9M+10.4% | $110.1M+31.8% | $90.1M+3.2% | $95.3M-4.1% | $86.9M-2.5% | $83.5M-56.5% | $87.3M+93.2% |
| Operating Income | -$137.8M-309.8% | $5.5M-76.3% | -$59.7M-161.1% | $61.7M-2.8% | $65.7M+26.2% | $23.2M-54.1% | $97.7M+144.8% | $63.5M+113.8% |
| EBITDA | -$18.0M-111.5% | $112.0M-4.7% | $35.7M-80.4% | $163.3M+3.7% | $156.3M+7.2% | $117.5M-18.1% | $182.5M+241.6% | $157.4M+143.4% |
| Interest Expense | $26.2M-4.8% | $25.6M-9.9% | $22.3M-19.7% | $25.4M-19.2% | $27.5M-16.7% | $28.4M-12.5% | $27.8M-17.1% | $31.4M-2.7% |
| Income Tax | -$21.2M-164.8% | -$5.2M-715.5% | $6.7M-65.5% | $10.6M+31.3% | $32.8M+352.3% | $850K-87.1% | $19.3M+206.6% | $8.1M+123.3% |
| Net Income | -$133.9M-1012.7% | -$16.0M-122.6% | -$102.8M-304.5% | $24.5M+7.2% | $14.7M-24.5% | -$7.2M-237.7% | $50.3M+119.7% | $22.9M+105.0% |
| EPS (Basic) | -$0.99-1090.0% | -$0.12-140.0% | -$0.74-317.6% | $0.17+6.3% | $0.10-23.1% | -$0.05-150.0% | $0.34+117.8% | $0.16+104.7% |
| EPS (Diluted) | -$0.99-1090.0% | -$0.12-140.0% | -$0.73-314.7% | $0.16+6.7% | $0.10-23.1% | -$0.05-150.0% | $0.34+117.5% | $0.15+104.4% |
| Diluted Shares (Avg) | 136M-0.7% | 136M+0.7% | N/A | 137M+0.5% | 137M+0.8% | 135M+1.4% | N/A | 137M+1.1% |
Not reported in any period shown, so not listed: R&D Expenses.
AHCO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.3B-0.2% | $4.4B-0.3% | $4.3B-3.8% | $4.4B-1.9% | $4.4B-3.5% | $4.4B-1.5% | $4.5B-0.5% | $4.5B-5.4% |
| Current Assets | $797.5M+21.2% | $687.5M-7.7% | $728.9M-3.6% | $724.8M+6.0% | $658.0M-4.1% | $745.2M+13.6% | $755.8M+16.5% | $683.8M+16.9% |
| Cash & Equivalents | N/A | $48.0M-10.6% | $106.1M-3.3% | $80.4M-19.8% | $68.6M-1.7% | $53.6M-32.6% | $109.7M+42.3% | $100.2M+78.4% |
| Short-Term Investments | N/A | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $105.5M-29.1% | $159.3M+23.2% | $114.9M-17.8% | $149.1M+11.7% | $148.9M+20.1% | $129.3M+19.1% | $139.8M+23.1% | $133.5M+14.7% |
| Accounts Receivable | $390.4M-0.8% | $392.0M-6.3% | $370.9M-9.1% | $380.3M-5.2% | $393.6M-9.9% | $418.5M-2.6% | $408.0M+4.9% | $401.2M+8.2% |
| Long-Term Investments | N/A | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $2.4B-10.6% | $2.6B-2.6% | $2.5B-8.1% | $2.7B-2.0% | $2.7B-2.2% | $2.6B-3.1% | $2.7B-1.8% | $2.7B-11.0% |
| Total Liabilities | $3.0B+7.2% | $2.9B+1.6% | $2.8B-4.1% | $2.8B-6.4% | $2.8B-8.7% | $2.9B-5.6% | $2.9B-4.4% | $2.9B-1.3% |
| Current Liabilities | $709.2M+14.0% | $743.3M+28.9% | $712.4M+25.6% | $670.7M+21.3% | $622.1M+4.4% | $576.7M+17.1% | $567.0M+5.6% | $553.0M+23.4% |
| Non-Current Liabilities | $2.2B+5.2% | $2.2B-5.3% | $2.1B-11.3% | $2.1B-12.7% | $2.1B-11.9% | $2.3B-10.0% | $2.3B-6.5% | $2.4B-5.7% |
| Long-Term Debt | $1.9B+4.9% | $1.8B-7.3% | $1.7B-12.7% | $1.7B-13.4% | $1.8B-12.1% | $1.9B-10.1% | $2.0B-6.2% | $2.0B-5.3% |
| Total Equity | $1.4B-13.2% | $1.5B-3.9% | $1.5B-3.3% | $1.6B+6.6% | $1.6B+6.8% | $1.6B+7.3% | $1.6B+7.7% | $1.5B-12.5% |
| Retained Earnings | -$782.9M-41.1% | -$649.0M-14.0% | -$633.0M-12.6% | -$530.2M+13.4% | -$554.7M+12.7% | -$569.4M+13.0% | -$562.2M+13.9% | -$612.4M-53.8% |
AHCO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $145.3M-10.3% | $93.7M-1.9% | $183.2M+21.8% | $161.1M+11.5% | $162.0M-18.2% | $95.5M+94.8% | $150.4M-3.1% | $144.4M+46.1% |
| Depreciation & Amortization | $119.8M+32.2% | $106.5M+12.9% | $97.5M+7.7% | $101.5M+8.1% | $90.6M-3.3% | $94.3M+1.6% | $90.5M-2.0% | $93.9M-4.3% |
| Stock-Based Compensation | $5.4M-10.0% | $6.5M+23.3% | N/A | $5.3M+488.9% | $6.0M+15.4% | $5.3M+16.8% | N/A | $900K-80.0% |
| Capital Expenditures | $166.2M+87.5% | $121.2M+26.8% | $103.9M+34.3% | $94.2M+58.2% | $88.7M+9.1% | $95.6M+8.8% | $77.3M-12.8% | $59.6M-22.7% |
| Free Cash Flow | -$20.9M-128.6% | -$27.5M-47296.6% | $79.3M+8.5% | $66.8M-21.2% | $73.3M-37.2% | -$58K+99.9% | $73.1M+9.7% | $84.8M+290.2% |
| Investing Cash Flow | -$202.7M-2210.7% | -$204.5M-113.9% | -$124.5M-43.3% | -$92.7M-71.0% | $9.6M+111.8% | -$95.6M-8.8% | -$86.9M+3.9% | -$54.2M+29.6% |
| Financing Cash Flow | $52.7M+133.7% | $52.6M+193.8% | -$32.9M+39.0% | -$56.6M+5.4% | -$156.6M-23.9% | -$56.0M-235.7% | -$54.0M-23.1% | -$59.8M-458.1% |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
AHCO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.1%-6.6pp | 13.6%-1.9pp | 19.3%-3.1pp | 19.7%-0.4pp | 20.7%-0.4pp | 15.5%-4.4pp | 22.4%-13.0pp | 20.1%+6.4pp |
| Operating Margin | -18.6%-28.6pp | 0.7%-2.3pp | -6.0%-17.4pp | 7.5%-0.3pp | 10.0%+3.5pp | 3.0%-3.4pp | 11.4%+36.8pp | 7.9%+65.2pp |
| Net Margin | -18.1%-20.3pp | -2.0%-1.0pp | -10.4%-16.3pp | 3.0%+0.1pp | 2.2%-0.2pp | -0.9%-0.7pp | 5.9%+35.5pp | 2.8%+59.3pp |
| Return on Equity | -9.7%-10.6pp | -1.1%-0.6pp | -6.8%-10.0pp | 1.5%0.0pp | 0.9%-0.4pp | -0.5%-0.3pp | 3.2%+20.7pp | 1.5%+27.7pp |
| Return on Assets | -3.1%-3.4pp | -0.4%-0.2pp | -2.4%-3.5pp | 0.6%0.0pp | 0.3%-0.1pp | -0.2%-0.1pp | 1.1%+6.8pp | 0.5%+10.1pp |
| Current Ratio | 1.12+0.1x | 0.92-0.4x | 1.02-0.3x | 1.08-0.2x | 1.06-0.1x | 1.290.0x | 1.33+0.1x | 1.24-0.1x |
| Debt-to-Equity | 1.36+0.2x | 1.190.0x | 1.13-0.1x | 1.08-0.2x | 1.13-0.2x | 1.24-0.2x | 1.25-0.2x | 1.33+0.1x |
| Asset Turnover | 0.170.0x | 0.190.0x | 0.230.0x | 0.190.0x | 0.150.0x | 0.180.0x | 0.190.0x | 0.180.0x |
| FCF Margin | -2.8%-14.0pp | -3.4%-3.3pp | 8.0%-0.5pp | 8.2%-2.4pp | 11.2%-3.3pp | 0.0%+4.9pp | 8.5%+0.8pp | 10.5%+7.8pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| AdaptHealth Corp. AHCO | FY2025 | $3.2B | -$70.8M | -2.2% | $808.5M | 29/100 |
| Integra LifeSciences Holdings IART | FY2025 | $1.6B | -$516.8M | -31.6% | $1.0B | 37/100 |
| NovoCure Limited NVCR | FY2025 | $655.4M | -$136.2M | -20.8% | $1.7B | 63/100 |
| SS Innovations International Inc. SSII | FY2025 | $42.5M | -$12.1M | -28.5% | $529.0M | 39/100 |
| Beta Bionics, Inc. BBNX | FY2025 | $100.3M | -$73.2M | -73.0% | $951.1M | 66/100 |
| UFP Technologies Inc UFPT | FY2025 | $602.8M | $68.3M | 11.3% | $2.2B | 72/100 |
Where AdaptHealth Corp. Ranks
Frequently Asked Questions
What is AdaptHealth Corp.'s annual revenue?
AdaptHealth Corp. (AHCO) reported $3.2B in total revenue for fiscal year 2025. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is AdaptHealth Corp.'s revenue growing?
AdaptHealth Corp. (AHCO) revenue declined by 0.5% year-over-year, from $3.3B to $3.2B in fiscal year 2025.
Is AdaptHealth Corp. profitable?
No, AdaptHealth Corp. (AHCO) reported a net income of -$70.8M in fiscal year 2025, with a net profit margin of -2.2%.
What is AdaptHealth Corp.'s EBITDA?
AdaptHealth Corp. (AHCO) had EBITDA of $472.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does AdaptHealth Corp. have?
As of fiscal year 2025, AdaptHealth Corp. (AHCO) had $106.1M in cash and equivalents against $1.7B in long-term debt.
What is AdaptHealth Corp.'s gross margin?
AdaptHealth Corp. (AHCO) had a gross margin of 18.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is AdaptHealth Corp.'s operating margin?
AdaptHealth Corp. (AHCO) had an operating margin of 2.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is AdaptHealth Corp.'s net profit margin?
AdaptHealth Corp. (AHCO) had a net profit margin of -2.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is AdaptHealth Corp.'s return on equity (ROE)?
AdaptHealth Corp. (AHCO) has a return on equity of -4.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is AdaptHealth Corp.'s free cash flow?
AdaptHealth Corp. (AHCO) generated $219.4M in free cash flow during fiscal year 2025. This represents a -7.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is AdaptHealth Corp.'s operating cash flow?
AdaptHealth Corp. (AHCO) generated $601.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are AdaptHealth Corp.'s total assets?
AdaptHealth Corp. (AHCO) had $4.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are AdaptHealth Corp.'s capital expenditures?
AdaptHealth Corp. (AHCO) invested $382.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is AdaptHealth Corp.'s current ratio?
AdaptHealth Corp. (AHCO) had a current ratio of 1.02 as of fiscal year 2025, which is considered adequate.
What is AdaptHealth Corp.'s debt-to-equity ratio?
AdaptHealth Corp. (AHCO) had a debt-to-equity ratio of 1.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is AdaptHealth Corp.'s return on assets (ROA)?
AdaptHealth Corp. (AHCO) had a return on assets of -1.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is AdaptHealth Corp.'s P/E ratio?
AdaptHealth Corp. (AHCO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $808.5M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AdaptHealth Corp.'s price-to-sales ratio?
AdaptHealth Corp. (AHCO) trades at 0.2x sales, its market capitalization divided by revenue of $3.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $808.5M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is AdaptHealth Corp.'s Altman Z-Score?
AdaptHealth Corp. (AHCO) has an Altman Z-Score of 0.79, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is AdaptHealth Corp.'s Piotroski F-Score?
AdaptHealth Corp. (AHCO) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are AdaptHealth Corp.'s earnings high quality?
AdaptHealth Corp. (AHCO) reported a net loss of $70.8M while generating $601.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can AdaptHealth Corp. cover its interest payments?
AdaptHealth Corp. (AHCO) has an interest coverage ratio of 0.88x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is AdaptHealth Corp.?
AdaptHealth Corp. (AHCO) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.